Trial intelligence / Profile preview

Atorvastatin in Active Vitiligo

NCT02432534Phase 2Completed

Sponsor
Centre Hospitalier Universitaire de Nice
Start
May 2015
Primary completion
Feb 2017
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of atorvastatin in Vitiligo, sponsored by Centre Hospitalier Universitaire de Nice. Started May 2015; status: completed.

02

Drugs

atorvastatin
03

Conditions

Vitiligo

Beyond the preview

Go deeper on NCT02432534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02432534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call